Tucatinib Together With Pembrolizumab and Trastuzumab
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|HER2-positive Breast Cancer
Interventions: DRUG: Tucatinib|DRUG: Pembrolizumab|DRUG: Trastuzumab|DRUG: Capecitabine
Sponsor: Breast Cancer Trials, Australia and New Zealand